These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Fiberoptic bronchoscopy in a community hospital. DiBenedetto RJ, Summers RS, DeBorde RJ, Covington SC, Causey DE. J Med Assoc Ga; 1979 Sep; 68(9):815-8. PubMed ID: 479715 [No Abstract] [Full Text] [Related]
28. Flexible fiberoptic bronchoscopy: its role in diagnosis of lung lesions. Corsello BF, Funahashi A, Hranicka LJ. Postgrad Med; 1982 Aug; 72(2):95-105, 108. PubMed ID: 7100018 [Abstract] [Full Text] [Related]
29. Tumour markers in dermatomyositis: useful or useless? O'Gradaigh D, Merry P. Br J Rheumatol; 1998 Aug; 37(8):914. PubMed ID: 9734687 [No Abstract] [Full Text] [Related]
30. Serum TPS versus TPA in Egyptian bladder cancer patients. Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P. Int J Biol Markers; 1993 Aug; 8(4):221-6. PubMed ID: 7511149 [Abstract] [Full Text] [Related]
31. [The serum levels of human calcitonin (hCT) and salmon calcitonin (sCT) in lung cancer patients]. Yiin KT, Chiang CD, Chen CF, Wang SJ, Lin WH, Guu CJ, Lee HK, Jih KS, Lin TM, Huang WL. Zhonghua Yi Xue Za Zhi (Taipei); 1987 Dec; 40(6):517-22. PubMed ID: 3502872 [No Abstract] [Full Text] [Related]
34. Prospective investigation of tumor markers and risk assessment in early cancer screening. Prados MC, Alvarez-Sala R, Garcia Rio FJ, Villamor J. Cancer; 1994 Sep 01; 74(5):1652-3. PubMed ID: 8062200 [No Abstract] [Full Text] [Related]
35. [Fiber optic bronchoscopy in bronchogenic carcinoma]. Greisen O, Eriksen HE, Bundgaard N. Ugeskr Laeger; 1987 Nov 16; 149(47):3195-7. PubMed ID: 3433515 [No Abstract] [Full Text] [Related]
36. Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. Giovanella L, Ceriani L, Bandera M, Beghe B, Roncari G. Int J Biol Markers; 1995 Nov 16; 10(3):156-60. PubMed ID: 8551058 [Abstract] [Full Text] [Related]
37. The use of fiberoptic bronchoscopy in the diagnosis of suspected pulmonary malignancy: Ramathibodi Hospital's experience with 542 patients. Vathesatogkit P, Charoenpan P, Kiatboonsri S, Samerkai V, Tansuphaswadikul S. J Med Assoc Thai; 1984 Mar 16; 67(3):176-81. PubMed ID: 6470591 [No Abstract] [Full Text] [Related]
38. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue. Gion M, Mione R, Barioli P, Sartorello P, Capitanio G. Eur J Clin Chem Clin Biochem; 1994 Oct 16; 32(10):779-87. PubMed ID: 7865616 [Abstract] [Full Text] [Related]
39. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA. Gion M, Mione R, Gatti C, Dittadi R, Leon A, Nascimben O, Pizzorno B, Bruscagnin G. Tumori; 1990 Aug 31; 76(4):360-4. PubMed ID: 2399565 [Abstract] [Full Text] [Related]